SCHEMBL19989544

SCHEMBL19989544

Cc1cc(S(=O)(=O)N[C@@H]2CCC[C@@H](C#N)C2)ccc1Br

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.52
▸ SMN1; SMN2 Q16637 2/20 0.46
▸ POLB P06746 1/20 0.46
▸ GAA P10253 1/20 0.46
▸ TSHR P16473 2/20 0.44
▸ TDP1 Q9NUW8 1/20 0.43
▸ CYP3A4 P08684 1/20 0.42
▸ MAPK1 P28482 1/20 0.42
▸ HTT P42858 1/20 0.42
▸ KDM4E B2RXH2 2/20 0.41
▸ RECQL P46063 1/20 0.41
▸ PDE4A P27815 1/20 0.41
▸ PDE4B Q07343 1/20 0.41
▸ PDE4C Q08493 1/20 0.41
▸ PDE4D Q08499 1/20 0.41
▸ CTSL P07711 2/20 0.39
▸ CTSS P25774 2/20 0.39
▸ CTSK P43235 2/20 0.39
▸ CTSC P53634 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29859404 1.00 ALDH1A1 (0.52) ALDH1A1SMN1; SMN2POLBGAATSHR
SCHEMBL19989477 0.85 ALDH1A1 (0.53) ALDH1A1SMN1; SMN2POLBGAATSHR
SCHEMBL19989476 0.85 ALDH1A1 (0.53) ALDH1A1SMN1; SMN2POLBGAATSHR
SCHEMBL29859453 0.85 ALDH1A1 (0.53) ALDH1A1SMN1; SMN2POLBGAATSHR
SCHEMBL29498503 0.82 ALDH1A1 (0.56) ALDH1A1SMN1; SMN2POLBGAATSHR
SCHEMBL19989453 0.82 ALDH1A1 (0.56) ALDH1A1SMN1; SMN2POLBGAATSHR
SCHEMBL19994841 0.81 ALDH1A1 (0.73) ALDH1A1SMN1; SMN2POLBGAATSHR
SCHEMBL2372122 0.79 ALDH1A1 (0.65) ALDH1A1SMN1; SMN2POLBGAATSHR
SCHEMBL19989269 0.77 ALDH1A1 (0.51) ALDH1A1SMN1; SMN2POLBGAATSHR
SCHEMBL29498556 0.77 ALDH1A1 (0.51) ALDH1A1SMN1; SMN2POLBGAATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109715608-B Indazole compounds for use in tendon and/or ligament injuries 诺华股份有限公司 2022-08-05 — — CN disclosed
EP-3515894-B1 INDAZOLE COMPOUNDS FOR USE IN TENDON AND/OR LIGAMENT INJURIES NOVARTIS AG (CH) 2021-04-07 — — EP disclosed
EP-3515894-A1 INDAZOLE COMPOUNDS FOR USE IN TENDON AND/OR LIGAMENT INJURIES Novartis AG (CH) 2019-07-31 — — EP disclosed
US-10112907-B2 Substituted indazoles for treating tendon and/or ligament injuries NOVARTIS AG (CH) 2018-10-30 — — US disclosed
US-20180086716-A1 Indazole Compounds for Use in Tendon and/or Ligament Injuries NOVARTIS INSTITUTE FOR FUNCTIONAL GENOMICS, INC., DBA THE GENOMICS INSTITUTE OF THE NOVARTIS RESEARCH FOUNDATION 2018-03-29 — — US disclosed
WO-2018055550-A1 INDAZOLE COMPOUNDS FOR USE IN TENDON AND/OR LIGAMENT INJURIES NOVARTIS AG (CH) 2018-03-29 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10112907-B2 Substituted indazoles for treating tendon and/or ligament injuries SLC10A2, MMP1, TNNI3 ALDH1A1 442/4885SMN1; SMN2 2255/4885POLB 3965/4885
US-20180086716-A1 Indazole Compounds for Use in Tendon and/or Ligament Injuries MMP1, SLC10A2, TNNI3 ALDH1A1 414/4885SMN1; SMN2 2704/4885POLB 3540/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback